HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Xie Selected Research

of childhood progressive pseudorheumatoid Arthropathy

1/2008[Construction of WISP3 gene's mutants in SEDT-PA and their expression in COS-7 cells].
12/2007WISP3 suppresses insulin-like growth factor signaling in human chondrocytes.
9/2007Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation.
5/2005[Proliferation, differentiation, and gene expression profile of osteoblast of patient with spondyloepiphyseal dysplasia tarda with progressive arthropathy].
1/2005[Characterization of biologic behaviors and cDNA expression of articular chondrocytes in spondyloepiphyseal dysplasia tarda with progressive arthropathy].
11/2004[Pathology and molecular pathogenesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy caused by compound CCN6 heterogeneous gene mutations].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Xie Research Topics

Disease

96Neoplasms (Cancer)
08/2022 - 03/2010
25Breast Neoplasms (Breast Cancer)
08/2022 - 12/2012
24Inflammation (Inflammations)
10/2021 - 11/2006
22Infections
12/2022 - 08/2012
22Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2013
21Prostatic Neoplasms (Prostate Cancer)
07/2022 - 01/2003
19Hypoxia (Hypoxemia)
10/2020 - 01/2003
17Carcinogenesis
08/2022 - 06/2013
17Wounds and Injuries (Trauma)
01/2022 - 03/2011
15Neoplasm Metastasis (Metastasis)
01/2022 - 11/2013
12Osteoporosis
12/2022 - 01/2006
12Poisoning
05/2021 - 12/2012
12Insulin Resistance
08/2017 - 05/2005
11Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2021 - 12/2012
11Glioma (Gliomas)
03/2018 - 03/2010
9Bone Resorption
01/2022 - 02/2005
9Body Weight (Weight, Body)
01/2021 - 07/2004
8Pain (Aches)
01/2022 - 04/2011
8Fibrosis (Cirrhosis)
04/2020 - 12/2012
8Type 2 Diabetes Mellitus (MODY)
01/2020 - 07/2004
8Obesity
08/2017 - 11/2009
7Triple Negative Breast Neoplasms
08/2022 - 01/2016
7COVID-19
07/2022 - 05/2020
7Stroke (Strokes)
01/2022 - 07/2011
7Osteonecrosis (Kienbock's Disease)
01/2022 - 01/2015
7Urinary Bladder Neoplasms (Bladder Cancer)
05/2021 - 01/2018
7Weight Loss (Weight Reduction)
01/2021 - 03/2007
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 03/2015
6Carcinoma (Carcinomatosis)
05/2021 - 10/2014
6Lung Neoplasms (Lung Cancer)
01/2021 - 06/2015
6of childhood progressive pseudorheumatoid Arthropathy
01/2008 - 11/2004
5Osteoarthritis
11/2022 - 01/2016
5Oral Submucous Fibrosis
04/2021 - 12/2012
5Stomach Neoplasms (Stomach Cancer)
02/2020 - 01/2016
5Brain Neoplasms (Brain Tumor)
01/2020 - 01/2011
4Postmenopausal Osteoporosis
12/2022 - 02/2014
4Adenocarcinoma
01/2022 - 05/2018
4Necrosis
10/2021 - 11/2013
4Adenocarcinoma of Lung
09/2021 - 01/2018
4Sepsis (Septicemia)
04/2021 - 09/2019
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2013
4Alzheimer Disease (Alzheimer's Disease)
11/2020 - 11/2012
4Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 05/2019
4Brain Ischemia (Cerebral Ischemia)
04/2018 - 07/2011
4Prostatitis
07/2010 - 04/2006

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2003
36Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2006
22Long Noncoding RNAIBA
05/2022 - 01/2013
19Pharmaceutical PreparationsIBA
06/2022 - 10/2014
17Messenger RNA (mRNA)IBA
01/2022 - 02/2007
14MicroRNAs (MicroRNA)IBA
11/2021 - 12/2009
13Biological ProductsIBA
05/2021 - 01/2005
13CytokinesIBA
01/2021 - 07/2010
11Glucose (Dextrose)FDA LinkGeneric
08/2022 - 11/2006
11RNA (Ribonucleic Acid)IBA
01/2022 - 07/2018
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2005
10ParaquatIBA
01/2021 - 12/2012
9Insulin (Novolin)FDA Link
07/2015 - 07/2004
8CollagenIBA
12/2021 - 12/2007
7Therapeutic UsesIBA
08/2022 - 08/2012
7GlucocorticoidsIBA
01/2022 - 04/2010
7LipidsIBA
04/2021 - 07/2004
7Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 03/2009
7CateninsIBA
10/2020 - 09/2013
6Hormones (Hormone)IBA
01/2022 - 01/2010
5Oxygen (Dioxygen)IBA
06/2022 - 04/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 02/2012
5Carrier Proteins (Binding Protein)IBA
10/2021 - 01/2020
5AntigensIBA
07/2021 - 01/2017
5Fatty Acids (Saturated Fatty Acids)IBA
05/2021 - 03/2007
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2010
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2018
5Histone Deacetylase InhibitorsIBA
06/2020 - 06/2013
5Cisplatin (Platino)FDA LinkGeneric
06/2020 - 01/2017
5Pioglitazone (Actos)FDA Link
04/2016 - 07/2004
5member 1 small inducible cytokine subfamily EIBA
02/2015 - 03/2010
4Sorafenib (BAY 43-9006)FDA Link
08/2022 - 10/2019
4LigandsIBA
06/2022 - 10/2013
4SilverIBA
01/2022 - 01/2020
4SteroidsIBA
01/2022 - 12/2011
4Transcription Factors (Transcription Factor)IBA
10/2021 - 05/2013
4CurcuminIBA
04/2021 - 02/2012
4CholesterolIBA
01/2021 - 12/2009
4Epidermal Growth Factor (EGF)IBA
01/2021 - 10/2008
4CreatinineIBA
10/2020 - 01/2013
4Phosphotransferases (Kinase)IBA
10/2019 - 01/2016
4theasinensin AIBA
01/2019 - 06/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 12/2012
4trichostatin A (A 300)IBA
01/2019 - 06/2013

Therapy/Procedure

58Therapeutics
08/2022 - 11/2012
14Drug Therapy (Chemotherapy)
01/2022 - 10/2014
10Immunotherapy
06/2022 - 01/2019
6Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2022 - 04/2011
6Ovariectomy (Oophorectomy)
01/2022 - 05/2013
6Aftercare (After-Treatment)
09/2018 - 01/2005
5Length of Stay
07/2022 - 07/2015
5Prostatectomy (Retropubic Prostatectomy)
01/2022 - 07/2013
5Intravenous Injections
01/2021 - 01/2016
4Neoadjuvant Therapy
01/2022 - 01/2019
4Radiofrequency Ablation
03/2018 - 01/2014